The sheer scale of the evidence base gives the finding unusual weight for a field often dominated by small regional surveys. Yet the pooled figure conceals enormous variability between studies, with an I-squared heterogeneity statistic of 99.7 percent, meaning nearly all the variance in reported prevalence reflects differences in study design, geography, diagnostic criteria, and population characteristics rather than sampling noise alone. Several regional estimates rested on a single study, so the authors caution that the true national picture may differ from the pooled average. Prevalence surged in parallel with rapid urbanisation and distinctive environmental exposures, a pattern consistent with the hygiene hypothesis and with documented rises in allergic disease across low- and middle-income countries undergoing swift economic transformation.

Beyond prevalence, the meta-analysis synthesised observational evidence on factors associated with allergic rhinitis, identifying a constellation of demographic, familial, clinical, and environmental correlates. Male sex emerged as a consistent demographic risk marker, echoing international findings that boys carry higher odds of allergic rhinitis during childhood, with the sex gap often narrowing or reversing after puberty. Caesarean delivery also appeared among the associated factors, a result that aligns with mechanistic hypotheses about birth mode and the developing immune system: infants born surgically miss exposure to the maternal vaginal microbiome, potentially altering early immune programming and skewing Th1-Th2 balance toward the allergic phenotype.

Family history proved among the strongest correlates. Parental allergy, family history of atopic disease, and personal asthma diagnosis each raised the odds of allergic rhinitis, consistent with the substantial heritability of allergic conditions and with the clinical reality that allergic rhinitis, asthma, and eczema frequently coexist as manifestations of a shared atopic diathesis. Antibiotic exposure during the first year of life was likewise associated with higher odds, a finding that fits hypotheses linking early disruption of gut microbiota to immune dysregulation, though the observational design cannot determine whether antibiotics themselves, the infections prompting them, or confounding factors such as healthcare utilisation drive the association.

Environmental tobacco smoke exposure, whether in the home or more broadly, was associated with increased odds of allergic rhinitis, adding to the extensive literature linking secondhand smoke to pediatric respiratory morbidity. Tobacco smoke irritates airway mucosa, impairs mucociliary clearance, and promotes inflammatory pathways that may sensitise the nasal epithelium to allergens. Having no siblings also emerged as a correlate, a result consistent with the hygiene hypothesis, which proposes that siblings bring infections and microbial exposures that train the developing immune system away from allergic responses. Home redecoration during infancy showed only a borderline association and should be interpreted cautiously, the authors note, since volatile organic compounds from paints and new furnishings have been proposed as respiratory irritants but the evidence here did not reach conventional thresholds of certainty.

Breastfeeding stood out as the one factor associated with lower odds of allergic rhinitis. Human milk delivers immunoglobulins, cytokines, and prebiotic oligosaccharides that shape the infant gut microbiome and support immune maturation, and prior cohorts have suggested protective or neutral effects on allergic outcomes. The meta-analysis result adds weight to the argument that breastfeeding may confer modest protection against allergic rhinitis in childhood, though the authors stress that observational associations of this kind are vulnerable to confounding by socioeconomic status, parental health behaviours, and reverse causation, and cannot establish causation.

The methodological apparatus behind the synthesis reflects contemporary standards for evidence appraisal. Study quality was evaluated using the Newcastle-Ottawa Scale for cohort and case-control studies and Joanna Briggs Institute criteria for cross-sectional designs. Meta-analysis employed random-effects or fixed-effect models depending on heterogeneity, and the team assessed publication bias, sensitivity, and between-study heterogeneity across the pooled estimates. The protocol was prospectively registered on PROSPERO under registration number CRD42024581359, providing transparency about the review questions and analysis plan before the literature search began.

The authors emphasise that the associations identified should not be read as causal. Because the included studies were observational, reverse causation, selection bias, and residual confounding remain plausible explanations for many of the reported relationships. Substantial heterogeneity across studies further complicates interpretation, since prevalence estimates varied markedly across regions and settings, and diagnostic criteria ranged from validated questionnaires such as ISAAC and SFAR to clinical diagnoses. The key message from the synthesis is that allergic rhinitis is common among Chinese children, that several early-life, familial, and environmental factors are associated with its occurrence, and that these relationships require confirmation in well-designed prospective studies before they can inform targeted prevention.

For clinicians and public health practitioners, the findings carry practical implications. A pooled prevalence of 16.1 percent suggests allergic rhinitis imposes a substantial burden on pediatric populations in China, with consequences for sleep quality, school performance, quality of life, and the risk of progression to asthma, a well-documented phenomenon known as the allergic march. The identification of modifiable correlates, particularly environmental tobacco smoke exposure and antibiotic use in infancy, points to potential intervention targets even before causal pathways are fully established. Reducing secondhand smoke exposure in households with children and promoting judicious antibiotic prescribing during the first year of life align with broader pediatric health goals and may plausibly reduce allergic disease risk, though definitive evidence will require longitudinal designs.

The study, published open access in BMC Pediatrics as a research article with no external funding, arrives at a moment of growing international attention to the pediatric allergy epidemic in rapidly urbanising societies. As China’s cities expand and environmental exposures shift, the trajectory of allergic rhinitis prevalence among children will depend on the interplay of genetic susceptibility, early-life microbial exposures, air quality, tobacco control, and healthcare access. This synthesis of more than 1.4 million children provides the most comprehensive snapshot to date of where that trajectory currently stands, and a benchmark against which future prevalence surveys and prospective cohort studies can measure progress in understanding and preventing one of the most common chronic conditions of childhood.

,

Subject of Research: Prevalence and risk factors of allergic rhinitis in Chinese children

Article Title: Prevalence and risk factors of allergic rhinitis in Chinese children: a systematic review and meta-analysis

Article References: Ke, H., Hao, C., Pu, X., Wei, P., & Yao, H. (2026). Prevalence and risk factors of allergic rhinitis in Chinese children: a systematic review and meta-analysis. BMC Pediatrics. https://doi.org/10.1186/s12887-026-07590-z

Image Credits: AI Generated

DOI: 10.1186/s12887-026-07590-z

Keywords: allergic rhinitis, Chinese children, meta-analysis, prevalence, risk factors, pediatric allergy, environmental tobacco smoke, breastfeeding, caesarean delivery, BMC Pediatrics, risk, factors

The starting point is a striking inconsistency in the epidemiological record. One small meta-analysis restricted to food allergy studies, led by Miyazaki and colleagues, pooled results from just three heterogeneous studies and found no statistically significant association between food allergy and ADHD, rating the certainty of the evidence as very low. Yet several individual observational studies have reported positive associations, some of them substantial. A Canadian primary care database study of nearly 288,490 children found an age- and sex-adjusted odds ratio of 1.81 for ADHD among children with physician-recorded food allergy. An Israeli retrospective cohort of 234,170 children reported an unadjusted odds ratio of 1.59. Large questionnaire datasets, including a Chinese school-age survey of more than 22,000 children and pooled U.S. National Health Interview Survey data covering 192,573 respondents, also reported elevated odds, although the American association weakened after adjustment for respiratory and skin allergies.

Why do these findings disagree? The review identifies a tangle of methodological problems that make the studies nearly impossible to compare. Some investigations relied on parent or caregiver reports of food allergy, which frequently fail to distinguish IgE-mediated immune reactions from food intolerance, aversion, or simple sensitization without clinical reactivity. Others used physician records or allergist diagnoses, which are more specific but still not uniformly challenge-confirmed. The ADHD side of the equation is equally variable: some studies used structured psychiatric interviews and formal diagnostic criteria, others used screening questionnaires such as the Strengths and Difficulties Questionnaire, and still others counted maternal reports of elevated symptoms. Temporal assessment varied too, with some studies measuring allergy and attention problems at the same moment and others tracking children over years.

That temporal distinction proved decisive in at least one landmark dataset. In the Great Smoky Mountains Study, a longitudinal community cohort of 1,420 children with 5,165 interview pairs, reported food or digestive allergies were associated with more concurrent ADHD symptoms, yielding a symptom mean ratio of 1.88. But when researchers looked prospectively, the association with subsequent symptom change collapsed to a nonsignificant 0.95, and cross-sectional ADHD diagnoses showed no significant link either. In other words, children with allergies had more attention symptoms at the same time point, but their allergies did not predict worsening attention over time. Similarly, in a cohort analysis by Ferro and colleagues, an association with elevated ADHD symptoms in adolescence appeared only in maternal reports, not in the adolescents’ own accounts, and the wide confidence interval left the finding imprecise.

Genetic tools offer another way to probe causality, and here too the picture is indirect. Mendelian randomization studies use genetic variants as natural experiments to test whether one condition causes another. One two-sample analysis reported a small association between genetically predicted ADHD and allergic asthma, but the result did not hold up under alternative statistical estimators or stricter instrument selection, and a subsequent commentary raised concerns about heterogeneity reporting and statistical power. A separate bidirectional analysis found an association between ADHD genetic liability and a broad childhood allergy phenotype, but food allergy was never analyzed as a distinct exposure in either study. The review concludes that no food allergy-specific causal estimate exists in the human literature.

What about the popular gut microbiome hypothesis? Preclinical work is genuinely intriguing. In an ovalbumin-induced food allergy mouse model, attention-related behavioral changes were accompanied by differences in prefrontal inflammatory markers, gut microbial composition, and serum metabolites. A follow-up experiment from the same group reported improvements in several behavioral measures after a multi-strain probiotic intervention. But the review is careful to note that attention tasks in mice do not establish ADHD, and that reduced intake, illness, stress, and immune activation could each influence the measured behaviors. On the human side, systematic reviews of the ADHD microbiome literature describe inconsistent taxon-level findings and substantial variation in diet, medication exposure, sequencing methods, and analysis. Pediatric food allergy studies report their own microbiome differences, but the two literatures have not been connected. No reproducible microbial biomarker or microbiome-directed treatment has been validated for children with both conditions.

The clinical burden of food allergy offers a more grounded explanation for why the two conditions might travel together without one causing the other. Constant vigilance about accidental exposure, restrictions at school, fear of reactions, and disrupted sleep can impair concentration and increase restlessness in any child. A preschool case-control study reported more emotional reactivity, somatic complaints, and sleep problems in children with food allergy, with behavioral difficulties linked to maternal anxiety and perceived child vulnerability. The influence may also run in reverse: difficulties with planning, inhibition, and sustained attention can complicate allergen avoidance and emergency preparedness, and children with ADHD have been reported to show more selective eating and sensory-related feeding features. Neither direction of influence, however, is equivalent to the persistent, cross-setting syndrome required for an ADHD diagnosis.

The practical implications are where the review becomes most consequential for families. Avoiding a confirmed allergen remains the cornerstone of food allergy treatment, but the authors are unequivocal that restrictive or elimination diets should not be routinely recommended to manage ADHD. Dietary intervention studies have reported symptom improvements in some cases, but small or selected samples, heterogeneous interventions, limited blinding, and uncertain durability prevented a favorable benefit-risk balance from being established. The TRACE follow-up study found less improvement and poorer adherence to an elimination diet than to a structured healthy diet trajectory over one year. Retrospective monitoring of the few-foods diet in general practice lacked a randomized comparator, and food-color challenge studies address a different exposure entirely. Meanwhile, additional restriction carries real risks: reduced energy and nutrient intake, worsened selective eating, reinforced fear-based avoidance, and potential contribution to avoidant/restrictive food intake disorder, a concern that looms largest for children already avoiding foods because of allergy.

Instead of dietary experiments, the review prescribes a coordinated clinical pathway. Allergy clinicians should verify the food allergy diagnosis, distinguishing immune-mediated reactions from intolerance and sensitization without reactivity, using skin-prick testing, food-specific IgE, and supervised oral food challenges where appropriate. Long-term avoidance should be reviewed whenever a diagnosis has not been firmly established. Medically necessary avoidance must still support normal growth, with guidance for cow’s milk allergy emphasizing adequate calcium and vitamin D and broader pediatric guidance recommending review of energy, protein, and overall nutrient intake. Dietitian input becomes especially important when several foods are excluded, when growth falters, or when ADHD medication suppresses appetite. When ADHD is suspected, assessment should establish clinically significant symptoms and impairment across more than one setting, confirm onset before age twelve, and consider alternative contributors such as pain, pruritus, anxiety, inadequate nutrition, and insufficient sleep.

The bottom line for families is sobering but clarifying. Some observational studies do report more ADHD diagnoses or symptoms among children with food allergy, but the current evidence establishes neither a consistent food allergy-specific association nor causation. Phenotype misclassification, uncertain temporal sequence, confounding, and indirect mechanistic evidence all limit what can be inferred. There is likewise insufficient evidence for routine probiotic use in ADHD management, despite the mechanistic appeal of the mouse data. Children with food allergy deserve careful attention to sleep, feeding, and emotional wellbeing, and persistent attention or behavioral concerns merit proper developmental assessment rather than dietary guesswork. The two conditions require evidence-based care each in its own right, with coordinated support when their clinical burdens intersect, and with research priorities aimed at clinically confirmed phenotypes, prospective designs, and explicit causal modeling to finally resolve whether the gut, the immune system, and the brain are truly linked in these children.

Subject of Research: The relationship between pediatric food allergy and attention-deficit/hyperactivity disorder, including epidemiological evidence, mechanistic hypotheses, and clinical dietary guidance

Article Title: Food allergy and attention-deficit/hyperactivity disorder in children: evidence and implications for pediatric allergy practice

Article References: Lu, B., & Xie, Y. (2026). Food allergy and attention-deficit/hyperactivity disorder in children: evidence and implications for pediatric allergy practice. Frontiers in Pediatrics, 14, Article 1982325. https://doi.org/10.3389/fped.2026.1982325

Image Credits: AI Generated

DOI: 10.3389/fped.2026.1982325

Keywords: food allergy, ADHD, children, pediatric allergy, elimination diet, gut microbiome, Mendelian randomization, observational studies, ARFID, nutrition, probiotics, clinical practice

The original study, led by Putri and colleagues, is unusually rigorous for a question this messy. The team used validated diagnostic algorithms to confirm asthma and allergy diagnoses, cross-referenced a national register of cats to determine which households actually kept one, and measured five distinct dimensions of asthma outcomes. They even ran a probabilistic bias analysis to account for the possibility that some cat-owning households were missed by the register. Their conclusion was blunt: blanket advice to avoid cats may not be uniformly beneficial for children who already have asthma and airway allergy.

But the Zurich commentators — Milad Ameri, Pål Johansen, and Marie-Charlotte Brüggen of the University of Zurich and the Christine Kühne Center for Allergy Research and Education — argue that the study’s central exposure variable deserves closer scrutiny. Cat ownership, they write, is a decision, not a dose. It reflects which families choose to keep a cat, not how much allergen a child actually breathes in. Once you take that distinction seriously, the behavior of families stops being background noise and becomes part of what the study is actually measuring.

The commentators point to a striking pattern in the Swedish data: severe allergic rhinitis at baseline was less common among children living with cats (11.5 percent) than among those without one (14.2 percent), even though initial asthma severity and parental atopy were comparable across groups. This hints at what epidemiologists call confounding by indication — parents may avoid getting a cat precisely because their child’s allergies are worse. The direction of this selection is not random, and it could bias the observed association toward showing no effect, even if a real effect exists.

How strong is this selection effect? A 1997 survey cited in the commentary offers a clue. Among 341 adults with diagnosed cat or dog allergy who had been explicitly advised by doctors to stop living with their animals, only 21.4 percent actually removed the pet or excluded it from the home. Among a subset of 122 whose animal had since died, 70.5 percent went on to acquire another. Families who relinquish a pet appear to be a minority — and they may represent a subgroup in whom allergic symptoms or medical advice have become severe enough to override the emotional bond. Cat-owning households, in other words, may be a self-selected population in which the presence of a cat has already proven tolerable.

The commentators also flag a subtler problem: the absence of a cat at home is not the same as the absence of cat exposure. Children classified as living without cats may still encounter substantial amounts of the major cat allergen, Fel d 1, through schools, childcare centers, relatives, and friends. This was demonstrated in Sweden itself, in a study co-authored by the senior author of the current commentary. Among more than 400 asthmatic children sensitized to cats but with no cat at home, those attending classrooms where more than 18 percent of classmates owned cats showed decreased peak expiratory flow, more symptom days, and greater medication use once the school term began. Passive allergen transport is real, measurable, and clinically meaningful.

There is also a question about how cat ownership was ascertained in the first place. Sweden’s National Cat Register was only established in 2023, and while the study authors appropriately modeled incomplete registration in their bias analysis, the commentators note that the cat-exposed group was markedly enriched for Nordic-born parents — 92.2 percent of mothers and 89.9 percent of fathers, compared with 78.9 percent and 77.7 percent in the non-exposed group. Cat ownership, in other words, is socially patterned. If the completeness of registration or record linkage varies with sociodemographic characteristics that are themselves related to asthma outcomes, the resulting misclassification could be differential — a form of bias that can push estimates in either direction, and one that a bias analysis assuming non-differential ascertainment cannot address.

None of this, the commentators stress, is meant to dispute the null finding, which was consistent across all five outcome measures. Rather, they argue that the behavioral constructs lurking behind ownership decisions are not impenetrable black boxes — they are measurable. Family attachment to the animal, for instance, can be quantified using validated instruments such as the Lexington Attachment to Pets Scale, a 23-item questionnaire, or its briefer seven-item version, which has been tested in more than 2,000 pet owners across three countries and shown to be measurement-invariant across four. Cat-keeping practices — whether the cat is allowed in the bedroom, kept indoors or outdoors, washed regularly, or fed an allergen-reducing diet — can be captured through structured exposure inventories and environmental Fel d 1 measurements.

Each of these constructs occupies a different position in the causal chain, and that position determines how it should be handled analytically. Attachment to the animal is a determinant of ownership and a confounder only if it also affects asthma independently of cat exposure; otherwise, it simply characterizes which families select into ownership. Cat-keeping and avoidance practices sit between ownership and actual allergen dose, so adjusting for them statistically would overadjust and mask real effects — but recording them would allow researchers to grade exposure by dose rather than by binary ownership status. Symptom attribution, the tendency of families to interpret a child’s breathing difficulties as cat-related, may itself be influenced by the outcome being studied and resists simple covariate adjustment.

The clinical implications could be significant. If blanket avoidance advice is not uniformly warranted, what replaces it is a conversation — one that depends on knowing how attached the family is, what practices they already follow, and what changes they are willing to make. And that conversation is increasingly backed by options that do not require giving up the pet at all. Allergen-reducing cat diets and experimental immunization of cats against Fel d 1, designed to induce neutralizing antibodies against the major feline allergen, have made what researchers call keep the cat, change the care pathway a testable clinical strategy rather than a slogan. The Zurich commentators propose that the field stop treating the human–animal bond as an unmeasured limitation and start recording it systematically — because the real question is not simply whether cat-owning families differ in asthma outcomes, but whether any difference reflects allergen dose or the selection of families into ownership in the first place.

Subject of Research: The relationship between household cat exposure and asthma outcomes in children with asthma and allergy

Article Title: Commentary: Cat exposure and asthma outcomes in a cohort of children with asthma and allergy

Article References: Ameri, M., Johansen, P., & Brüggen, M.-C. (2026). Commentary: Cat exposure and asthma outcomes in a cohort of children with asthma and allergy. Frontiers in Allergy, 7, Article 1997917. https://doi.org/10.3389/falgy.2026.1997917

Image Credits: AI Generated

DOI: 10.3389/falgy.2026.1997917

Keywords: asthma, cat allergy, Fel d 1, allergen exposure, pet ownership, confounding by indication, exposure misclassification, human-animal bond, pediatric allergy, register-based epidemiology, allergen avoidance, Lexington Attachment to Pets Scale

The logic behind the trial is deceptively simple. Ecological studies have repeatedly shown that the risk of food allergy increases the further a child lives from the equator, a gradient that tracks with declining ultraviolet B exposure and lower vitamin D status. The Melbourne team behind VITALITY had previously demonstrated that infants with vitamin D deficiency, defined as levels at or below 50 nanomoles per litre, were significantly more likely to have challenge-proven food allergy at twelve months of age, with an adjusted odds ratio of 3.4. Strikingly, that association was modified by parental country of birth: it was strong in infants of Australian-born parents but absent in those with at least one parent born overseas. Biologically, the hypothesis is plausible, because vitamin D is known to be critical to the healthy development and maintenance of the immune system in early life, and it may also influence airway remodelling relevant to asthma.

What makes Australia the ideal laboratory for this question is an accident of public health policy. Unlike many Northern Hemisphere countries, Australia does not routinely fortify its food supply with vitamin D, and it has no population-level recommendation for routine infant supplementation. That means researchers can randomise babies to supplementation or placebo without the background noise of widespread fortification or supplementation contaminating the comparison. VITALITY exploited this natural experiment, enrolling healthy, term, predominantly breastfed, vitamin D-unsupplemented infants across Greater Melbourne between December 2014 and April 2022.

The trial design was rigorous. Infants were randomised to receive either 400 International Units of vitamin D3 as cholecalciferol, one drop per day, or an identical-looking placebo drop of vegetable oil, starting between six and twelve weeks of age and continuing until twelve months. The primary objective was to determine whether supplementation reduces the prevalence of food allergy at twelve months, assessed not by parental report but by the gold standard: skin prick testing followed, where indicated, by supervised oral food challenges. Secondary outcomes included food sensitisation, vitamin D deficiency, doctor-diagnosed eczema, infection episodes, wheeze episodes and allergy-related healthcare use during the first year. The trial was originally powered to detect a 32.5 percent reduction in food allergy from an assumed prevalence of ten percent, but midway through, with updated data showing a 12.4 percent allergy prevalence among breastfed infants, the sample size was recalculated to detect a 30 percent reduction from twelve to eight percent, requiring 2,330 infants.

Recruitment was a feat of persistence. Of 13,537 infants approached through immunisation and maternal-child health clinics across every local government area of Greater Melbourne, 5,679 were eligible, and 2,739 families proceeded to randomisation, a 48.2 percent recruitment rate among those eligible. Then came COVID-19. Melbourne endured 262 days of lockdown across six periods between March 2020 and October 2021, forcing face-to-face recruitment to a halt. The team pivoted to online methods, launching targeted carousel advertisements on Facebook and Instagram aimed at families with newborns. The strategy worked remarkably well: interested families, already familiar with the eligibility criteria from the ads, contacted the study team, and recruitment rates returned to near pre-pandemic levels despite ongoing restrictions.

Retention proved equally impressive. Despite the pandemic, more than 83 percent of participants completed either the twelve-month questionnaire or a short allergy questionnaire, and 78.8 percent attended the twelve-month clinic assessment at the Royal Children’s Hospital. Only 6.4 percent of participants were lost to follow-up and 6.7 percent withdrew before their twelve-month assessment, with the most common reasons being that life was too busy or that giving the daily drops was too difficult. The families who joined were not a random slice of the population: 89.2 percent had a family history of allergic disease, and 61.2 percent had both parents born in Australia. Compared with the population-based HealthNuts and EarlyNuts studies from the same city, VITALITY participants showed a clear allergic bias, most likely because a prevention trial attracts families with lived experience of allergy. This is a limitation the investigators acknowledge openly, but it also means the cohort is enriched for the very outcomes it was designed to study.

The clinical work at twelve months was substantial. Skin prick tests were performed on 2,151 infants, testing sensitivity to cow’s milk, egg, peanut, cashew, almond, hazelnut, shellfish, wheat, sesame, soy and house dust mite. Five hundred infants, 23.3 percent of those tested, had a positive result to at least one food allergen, and 351 of them underwent a total of 612 oral food challenges, the definitive test of true clinical allergy. Of those challenges, 300 were positive, 303 negative and nine inconclusive. Every challenge was conducted under supervision, generating an objective diagnosis rather than the surrogate markers that plague much of the allergy literature.

What truly sets VITALITY apart, however, is the depth of its biological repository. Blood was collected at baseline, at twelve months and at the six-year follow-up, with peripheral blood mononuclear cells separated and frozen in liquid nitrogen for cytokine profiling, flow cytometry and RNA sequencing, and plasma stored at minus 80 degrees Celsius for biomarker analysis. Vitamin D levels were quantified using liquid chromatography-tandem mass spectrometry. At the baseline home visit, researchers collected infant stool, skin swabs from the antecubital fossa and cheek, maternal skin and nasal swabs, and breastmilk. Skin swabs and stool are being used for microbiome analysis, while stool and breastmilk undergo metabolomic profiling. These samples have already yielded results: the skin swabs contributed to a comprehensive genome catalogue of the early-life human skin microbiome, and are now being evaluated for their role in eczema development. Questionnaires at baseline and at six, nine and twelve months captured demographics, environmental exposures, feeding behaviours and factors influencing vitamin D status, all managed through a REDCap electronic data platform.

The story is not over. A six-year follow-up began in 2023, motivated by findings from the HealthNuts study showing that infants with food allergy at one year go on to have lung function deficits and asthma at age six. The follow-up will assess whether early-life vitamin D supplementation can modulate the developing lung, and will track the persistence and emergence of new allergic diseases, lung function, infections and oral health, including dental plaque collection. The timepoint was deliberately aligned with other Melbourne cohorts to enable cross-cohort analyses using validated measures. The team is also linking records to Medicare and Pharmaceutical Benefits data, the Australian Childhood Immunisation Register, hospital admissions, emergency presentations, anaphylaxis notifications and perinatal records, extending linkage to the child’s seventh birthday. Because the cohort was recruited before and during the pandemic, its data also feed a seven-cohort consortium study that documented how COVID-19 disproportionately affected the most disadvantaged Australian families.

For the scientific community, VITALITY represents the first adequately powered study worldwide to test whether infant vitamin D supplementation can prevent allergic disease, and its randomised design means future analyses can adjust for, or stratify by, the intervention when exploring other exposure-outcome relationships. A pre-registered statistical analysis plan, published before any analyses began, specifies multiple imputation for missing data and confidence-interval-based reporting. Applications to access the data and biospecimens are welcomed through the Melbourne Children’s Lifecourse Initiative, meaning this resource will keep generating discoveries long after the primary trial results are known. Whether or not the daily drop of vitamin D turns out to be the answer to the food allergy epidemic, the infrastructure built to test that question, thousands of deeply phenotyped children, a multi-omics biobank spanning gut, skin, blood and breastmilk, and linked health records through early childhood, will shape allergy and immune health research for decades.

Subject of Research: A randomised trial and longitudinal cohort testing postnatal vitamin D supplementation for prevention of food allergy and atopic disease in infants

Article Title: VITALITY – a longitudinal cohort established to assess the role of postnatal vitamin D supplementation in atopic disease and immune health

Article References: Eckert, J. K., Walsh, A., Young, A., Parker, K. M., Odoi, A., Zannino, D., Dawes, K., Koplin, J. J., Peters, R. L., Lee, K. J., Saffery, R., Dharmage, S. C., Allen, K. J., Perrett, K. P., & the VITALITY Team (2026). VITALITY – a longitudinal cohort established to assess the role of postnatal vitamin D supplementation in atopic disease and immune health. European Journal of Epidemiology. https://doi.org/10.1007/s10654-026-01437-8

Image Credits: AI Generated

DOI: 10.1007/s10654-026-01437-8

Keywords: vitamin D, food allergy, VITALITY trial, infant health, atopic disease, eczema, randomised controlled trial, longitudinal cohort, microbiome, immune health, asthma, pediatric allergy

The research team, based at the asthma and allergy clinic of Shahid Beheshti Hospital and affiliated with Kashan University of Medical Sciences, combed through electronic medical files from January 2005 to December 2021. Their inclusion criteria were strict: infants between six and twenty-four months of age with a diagnosis of atopic dermatitis and a completed skin prick test panel. Babies whose medications could not be safely paused, those with severe skin disease other than eczema, and any infant with a history of anaphylaxis to food were excluded, as were patients with incomplete records. After applying these filters, ninety-eight infants made it into the final analysis, a modest but carefully characterized cohort that received ethics approval and parental informed consent for every case.

The skin prick test itself deserves a technical word, because its simplicity belies the immunology it captures. Clinicians placed standardized extracts of eight common food allergens—milk, egg, tree nuts, soybean, wheat, seafood, rice, and peanut—onto a small scratch on the palm side of the infant’s forearm. Antihistamines and systemic steroids were halted a full week beforehand to avoid blunting the response. After fifteen to twenty minutes, the site was inspected: a wheal greater than three millimeters, accompanied by erythema exceeding eight millimeters, counted as positive. The researchers then graded reactions by size, treating wheals of three to five millimeters as mild, five to ten as moderate, and anything beyond ten as severe. The test works by detecting allergen-specific immunoglobulin E, or IgE, antibodies parked on mast cells in the skin; when the extract cross-links those antibodies, the cells dump histamine and other inflammatory mediators, producing the visible swelling within minutes.

The headline result was unambiguous. Egg allergy appeared in 64.3 percent of the infants, cow’s milk in 49 percent, tree nuts in 35.7 percent, soy in 20.4 percent, and wheat in 12.2 percent. Girls made up the majority of the cohort at 55.1 percent, and most babies—66.3 percent—had mild disease, with 24.5 percent moderate and only 9.2 percent severe. The average age at which eczema first appeared was just under six months, at 5.72 months, underscoring how early in life the disease and its dietary entanglements begin. Feeding history in the first half-year was also recorded: 63.3 percent of infants were exclusively breastfed, 13.3 percent received only formula, and the rest a combination of the two.

Two statistically significant patterns emerged from the cross-tabulations. First, egg allergy was markedly more common in girls than in boys, affecting 74.1 percent of female infants versus 52.3 percent of males, a difference the authors reported as significant at p equals 0.025. Second, cow’s milk allergy clustered in early-onset disease: 56.06 percent of infants whose symptoms began before six months of age were sensitized to milk, compared with 34.3 percent of those whose eczema appeared later, significant at p equals 0.044. Wheat sensitization showed a striking fivefold elevation in the early-onset group, 16.6 percent versus 3.1 percent, but the small numbers in each subgroup kept this from reaching statistical significance. Notably, the type of allergen bore no relationship to how the infant was fed in the first six months, nor to the severity of the eczema itself.

Severity did, however, track tightly with timing. Infants with severe atopic dermatitis had developed symptoms at an average age of just 2.78 months, compared with 7.17 months in the moderate group and 5.60 months in the mild group, a difference significant at p equals 0.014. This aligns with a broader clinical observation that the earliest and most aggressive presentations of eczema often mark children destined for the so-called atopic march, the progression from skin disease to food allergy, allergic rhinitis, and asthma. Immunologically, atopic dermatitis is driven by a skewed T helper 2 response, with interleukins IL-4, IL-5, and IL-13 ramping up IgE production and activating eosinophils and mast cells. When food antigens enter this primed environment, B lymphocytes pump out allergen-specific IgE, which arms mast cells and basophils via their Fc receptors; re-exposure then triggers the full allergic cascade.

The Kashan results sit within a patchwork of international findings that highlight how geography and diet shape allergen profiles. A Chinese study of nearly 1,700 children under two identified egg, shrimp, and fish as leading triggers, while Iranian work in Mashhad found egg white, egg yolk, and cow’s milk at the top of the list. In Bushehr, southern Iran, peanuts, walnuts, and soybeans dominated, and Czech researchers reported nuts, milk, and peanuts as the chief offenders among older patients. The authors of the new study attribute this variability to differences in dietary habits, culture, ethnicity, and age of the studied populations, along with a straightforward epidemiological principle: the more a population consumes a given food, the more likely its members are to become sensitized to it. Cow’s milk and egg, staples of infant diets nearly everywhere, recur as the leading allergens across most regions, including prior Iranian surveys.

Perhaps the most consequential implication of the study is what it says about feeding practices. The researchers found no association between breastfeeding, formula feeding, or mixed feeding and either allergen sensitization or disease severity, a result consistent with systematic reviews that have failed to demonstrate a clear protective or predisposing effect of exclusive breastfeeding on atopic outcomes. This echoes earlier Iranian work showing that breastfeeding patterns and the timing of complementary foods did not influence eczema incidence or severity. The practical message is twofold: infant feeding choices alone cannot explain allergic outcomes without accounting for genetic susceptibility and immune mechanisms, and clinicians should resist reflexively prescribing long lists of foods to eliminate from both mother’s and baby’s diets, a practice the authors note can produce what they describe as double starvation and injury. Precise identification of the offending allergen, followed by targeted avoidance, is the strategy that actually improves quality of life.

The study is candid about its limits. Its retrospective design depended on medical records rather than prospective enrollment, more than forty-five cases were dropped for missing data, and the skin prick test, while valuable, detects sensitization rather than clinically confirmed allergy. Without confirmatory serum-specific IgE measurements or oral food challenges, the true prevalence of food allergy may have been overestimated. Moreover, atopic dermatitis comes in two immunological flavors: the extrinsic, IgE-mediated form that prick testing captures well, and the intrinsic, non-IgE-mediated form, in which patients show classic eczema despite normal IgE levels and negative tests. The Kashan findings therefore largely reflect sensitization patterns in extrinsic disease and may underestimate food-related triggers in intrinsic cases. The authors call for prospective, multicenter studies with larger samples, standardized severity scoring, and confirmatory diagnostics such as oral food challenges to sharpen the picture.

Even with those caveats, the sixteen-year dataset delivers a clear clinical takeaway. Infants with eczema in this Iranian population were most frequently sensitized to egg, cow’s milk, and nuts; egg sensitization skewed female, milk sensitization skewed toward early-onset disease, and the earliest symptom onset predicted the most severe eczema. Because food sensitivity in many patients begins before six months of age, the authors recommend that highly allergenic items such as egg yolk and wheat not be introduced into infant diets before that age. In an era when allergic diseases of every type are rising worldwide, region-specific maps of allergen frequency like this one are becoming essential instruments for pediatricians navigating the fine line between protecting vulnerable infants and depriving them of nutrition they can safely tolerate.

Subject of Research: Food allergen sensitization patterns in infants with atopic dermatitis assessed by skin prick testing

Article Title: Assessment of Common Food Allergens in Infants With Atopic Dermatitis in Kashan From 2005 to 2021

Article References: Madani, S. R., Salehi, M., Arani, M. H., Shaterian, Z., Heidari, M. M., & Azadchehr, M. J. (2026). Assessment of Common Food Allergens in Infants With Atopic Dermatitis in Kashan From 2005 to 2021. Immunity, Inflammation and Disease, 14(10), Article e70544. https://doi.org/10.1002/iid3.70544

Image Credits: AI Generated

DOI: 10.1002/iid3.70544

Keywords: atopic dermatitis, food allergy, infants, skin prick test, egg allergy, cow's milk allergy, IgE, eczema, Iran, pediatric allergy, breastfeeding, atopic march

The study, led by Han Wang of the Department of Pediatrics at the Second Hospital of Dalian Medical University, employed an umbrella review methodology — essentially a systematic review of systematic reviews — combined with standardized evidence-grading criteria adapted from the framework pioneered by Ioannidis and colleagues. Rather than accepting the conclusions of individual meta-analyses at face value, the team re-analyzed each reported association against a battery of quality filters. These included the statistical significance of the pooled effect estimate, the degree of heterogeneity among the underlying studies, the total sample size contributing to the estimate, evidence of small-study effects and publication bias detected through funnel plot asymmetry, and the results of exploratory tests for an excess of significant findings that might signal selective reporting.

Each of the 176 associations was assigned to one of four credibility tiers: strong, highly suggestive, suggestive, or weak or non-suggestive evidence. The outcome was stark. Beyond the three strong associations, only six earned the designation of highly suggestive — three based on binary outcomes and three on continuous outcomes after the authors applied a pragmatic minimum sample size criterion. Eight further associations were rated as merely suggestive. That leaves 159 of the 176 associations — roughly ninety percent — classified as weak or non-suggestive, meaning that the vast majority of claimed links between early-life exposures and pediatric allergic disease either dissolved under statistical scrutiny or rested on evidence too fragile to support confident conclusions.

The three survivors of the grading process are strikingly diverse. Neonatal jaundice, one of the most common conditions in newborn medicine, emerged as a strongly supported exposure associated with later allergic outcomes, a finding consistent with an updated meta-analysis by Kuniyoshi and colleagues published in Pediatric Allergy and Immunology. Pesticide exposure also reached the strong tier, echoing a 2024 systematic review in Frontiers in Public Health that linked children’s exposure to pesticides with asthma, wheezing, and lower respiratory tract infections. Perhaps most intriguing is the third: postnatal maternal depression, supported by a 2024 meta-analysis in PLOS One connecting perinatal maternal mental health with childhood asthma risk. Together, these findings point toward a risk landscape in which physical, chemical, and psychosocial exposures in early life may all converge on the developing immune system.

The methodological machinery behind these judgments deserves attention, because it explains why so many familiar associations failed. Heterogeneity — the statistical measure of how much the results of individual studies diverge from one another — was a recurring problem across the literature. When studies of the same exposure produce wildly different effect estimates, the pooled result becomes difficult to interpret, and the review’s grading criteria penalized such inconsistency heavily. Sample size mattered as well: meta-analyses built on a few small studies can produce impressive-looking pooled estimates that are statistically fragile and vulnerable to being overturned by a single larger trial. The authors also applied tests for excess significance, comparing the number of statistically significant studies in a meta-analysis against the number expected given the power of those studies — a discrepancy that often reveals publication bias or selective outcome reporting.

The implications extend well beyond academic bookkeeping. Clinical guidelines, public health recommendations, and parental advice about allergy prevention are frequently built on the assumption that observational associations reflect genuine causal relationships. If a mother is told that cesarean delivery, acid-suppressive medication, or a particular dietary choice during pregnancy will shape her child’s allergy risk, she deserves to know how solid that evidence actually is. This review suggests that for most such exposures, the honest answer is: not very. The authors explicitly caution that most associations lack sufficient evidence to support causal inference, and they emphasize that more robust evidence is needed before drawing causal or clinical conclusions from the existing literature.

That said, the review does identify domains that merit continued attention. Early-life and perinatal factors — the period spanning late pregnancy, birth, and the first months of postnatal life — feature prominently among the better-supported associations, as do environmental exposures such as pesticides. This aligns with a broader biological framework in which the developing immune system is calibrated by its early environment: the gut microbiota establishes itself in the first years of life, the mucosal immune system learns to distinguish threat from tolerance, and neuroimmune communication links psychological stress to inflammatory pathways. Recent reviews in Nature Reviews Immunology and Nature Reviews Drug Discovery have mapped these mechanisms in detail, and the umbrella review’s findings about maternal depression, in particular, resonate with the growing field of psychoneuroimmunology, which documents how maternal psychological states can influence immune signaling in offspring.

The review also functions as an implicit critique of the meta-analysis industry itself. Ioannidis famously warned in 2005 that most published research findings are false, and followed up in 2016 with a pointed analysis of the mass production of redundant, misleading, and conflicted systematic reviews and meta-analyses. The pediatric allergy literature, with its proliferation of meta-analyses on probiotics, vitamin D, hydrolyzed formula, immunotherapy, air pollution, and dozens of other exposures, illustrates the problem vividly. When many small observational studies with heterogeneous designs are pooled, the resulting effect estimates can appear authoritative while concealing deep uncertainty. Umbrella reviews like this one serve as a corrective, forcing the field to distinguish between associations that have survived multiple layers of scrutiny and those that merely accumulated citations.

For researchers, the roadmap forward is clear. The authors call for higher-quality evidence and more rigorous evaluation of environmental risk factors in pediatric allergy research — larger, better-designed prospective cohorts with standardized exposure assessment, pre-registered analyses that reduce the scope for selective reporting, and, where feasible, randomized interventions to test whether modifying an exposure actually changes allergy risk. Previous large randomized trials in this space, such as the PreventADALL trial of early food introduction and skin emollients and the BEEP trial of infant emollient use, offer templates for how causal questions in allergy prevention can be tested directly rather than inferred from observational data.

For parents and clinicians, the practical takeaway is one of calibrated humility. The evidence that neonatal jaundice, pesticide exposure, and postnatal maternal depression are associated with childhood allergic disease is strong enough to warrant attention — the first as a marker to monitor, the second as an exposure worth minimizing, and the third as a reminder that maternal mental health is inseparable from child health. But the long list of exposures that failed to earn strong or highly suggestive ratings should temper the confidence with which prevention advice is delivered. In a field where nearly ninety percent of published associations crumble under systematic re-evaluation, the most scientifically honest message may be that the search for the causes of childhood allergy is still, in crucial respects, just beginning — and that distinguishing genuine signals from statistical noise is now the field’s most urgent task.

Subject of Research: Evidence strength of exposure–outcome associations in pediatric allergic diseases, evaluated through an umbrella review of meta-analyses

Article Title: Evidence strength of exposure-outcome associations in pediatric allergic diseases: an umbrella review of meta-analyses

Article References: Wang, H., Hu, Q., Li, J., Chen, K., Qi, X., Zhang, R., Wang, X., Wang, Y., & Li, Y. (2026). Evidence strength of exposure-outcome associations in pediatric allergic diseases: an umbrella review of meta-analyses. Pediatric Research. https://doi.org/10.1038/s41390-026-05452-z

Image Credits: AI Generated

DOI: 10.1038/s41390-026-05452-z

Keywords: pediatric allergy, umbrella review, meta-analysis, asthma, eczema, food allergy, allergic rhinitis, neonatal jaundice, pesticide exposure, maternal depression, evidence grading, publication bias